BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12584388)

  • 1. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
    Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
    Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
    Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
    Lung; 2001; 179(4):197-207. PubMed ID: 11891611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
    Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
    Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
    Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
    Lung; 2003; 181(2):103-11. PubMed ID: 12953149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
    Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer.
    Chiou JF; Liang JA; Hsu WH; Wang JJ; Ho ST; Kao A
    Lung; 2003; 181(5):267-73. PubMed ID: 14705770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.
    Yeh JJ; Hsu NY; Hsu WH; Tsai CH; Lin CC; Liang JA
    Lung; 2005; 183(3):177-83. PubMed ID: 16078039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
    J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression.
    Hsia TC; Lin CC; Wang JJ; Ho ST; Kao A
    Lung; 2002; 180(3):173-9. PubMed ID: 12177731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
    Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
    Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.
    Safran H; King T; Choy H; Gollerkeri A; Kwakwa H; Lopez F; Cole B; Myers J; Tarpey J; Rosmarin A
    Cancer; 1996 Sep; 78(6):1203-10. PubMed ID: 8826941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
    Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
    Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
    Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.